Page last updated: 2024-10-25

cimetidine and Keratoacanthoma

cimetidine has been researched along with Keratoacanthoma in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baican, A1
Norris, DA1
Birlea, SA1

Other Studies

1 other study available for cimetidine and Keratoacanthoma

ArticleYear
Recalcitrant Grysbovski's keratoacanthomas with good response to cimetidine.
    The American journal of medicine, 2010, Volume: 123, Issue:4

    Topics: Cimetidine; Female; Histamine H2 Antagonists; Humans; Keratoacanthoma; Middle Aged

2010